Lithium is used in the prophylaxis of bipolar depressive disorder in augmentation treatment of depression and in the therapy of some cases of unipolar depression. Lithium 
INTRODUCTION
others. Since then, a large number of clinical and experi¬ mental studies on the effect of lithium on thyroid physiol-THE main use of lithium in therapeutics is in the treat-ogy have been performed and reviewed (4) (5) (6) . This article ment and prophylaxis of manic depressive psychosis, briefly reviews lithium effect on cellular metabolism prior In 1949, J.F.J. Cade, an Australian psychiatrist, noticed to describing its effects on thyroid pathophysiology and that guinea pigs that had been given lithium urate during thyrotropin-releasing hormone (TRH) . an investigation into the role of uric acid in manic patients became less startled (1) . This led to the trial administra¬ tion of lithium to manic depressive patients, and then to LITHIUM AND CELL FUNCTION the widely acclaimed studies of Schou and colleagues (2) which defined the clinical effectiveness of this ion in psyLithium has many actions on the cell including effects chiatry. In 1967 the occurrence of goiter in patients re-on adenosine triphosphatase (ATPase) activity, cyclic ceiving lithium was mentioned at a conference in Denmark adenosine monophosphate (cAMP) activity, intracellular and these data were reported in 1968 by Schou (3) (12) .
EFFECT OF LITHIUM ON THYROID PHYSIOLOGY
Lithium is concentrated by the thyroid (13) , but the re¬ lation of the thyroidal lithium concentrating mechanism to the iodide concentrating process is not clear. It is concen¬ trated in mouse salivary glands, which also actively con¬ centrate iodide, perhaps suggesting a common pathway. Lithium reduces the radioiodine (131I) uptake into rat thy¬ roid in vivo (14) and in vitro (15) and into mouse salivary gland (16) . In human, lithium administration may result in a reduced, as well as an increased thyroidal radioiodine uptake (17) . The possible reasons for this are that lithium causes iodide retention and the increase in uptake may also be due to TSH secreted as a result of lithium-induced hy¬ pothyroidism. Lithium inhibits the coupling of iodotyrosines to form iodothyronines in rat thyroid homogenates, but although thyroid hormone synthesis may be impaired, total iodination is not reduced (18) and the overall effect is mild. In humans there is no effect of lithium on the perchlorate discharge test, although if the sensitivity of this test is increased by iodide administration positive tests are seen (19) . Lithium may alter thyroglobulin structure by af¬ fecting protein conformation and function, thereby lead¬ ing to minor iodotyrosine coupling defects, but no in¬ hibitory effect of lithium has been observed on the biosynthesis or degradation of thyroglobulin in the rat (20) .
A reduction in 131I release rate has been found in rats given lithium (17) and reduced thyroxine (T4) release was demonstrated in both euthyroid and hyperthyroid patients receiving the drug (14) . Animal data suggests that the block may be distal to cAMP formation (21) in addition to the fact that the process of thyroid hormone secretion involves a decrease in colloid droplet formation together with a number of complex steps involving the degradation of thy¬ roglobulin (22) . Lithium does alter tubulin polymerization (23) , which may account for its inhibitory effect on hor¬ mone secretion. The significant decrease in T4 clearance from plasma in patients receiving lithium (24, 25) (26) , and humans (27) (41) . Clinically, the goiter is smooth and nontender. It may develop within weeks of starting lithium therapy (14) , or months to years of lithium treatment (39 (42) . The female to male ratio is about 5:1 with a significantly higher incidence in females, even when compared with the normally expected higher incidence of this condition in the general popula¬ tion (43) . In a review of 16 (52) .
